http://www.checkpointtx.com
Checkpoint Therapeutics, Inc. Company Intro
Industry
Healthcare
Checkpoint Therapeutics, Inc. Headquaters
2 Gansevoort Street
New York,10014
United States
Checkpoint Therapeutics, Inc. Share price
21 Oct 2020 01:21 GMT
$2.3900
0.02 (0.84 %)
Checkpoint Therapeutics, Inc. Market cap
$165.415 M
WMC RANKING
2020
Checkpoint Therapeutics, Inc. # 225
BiotechnologyLatest Checkpoint Therapeutics, Inc. News
20 Oct 2020
Immune Checkpoint Inhibitors Market – Key Development by ...
Merck & Co. Roche / Genentech. Incyte Corporation. NewLink Genetics. ArGEN-X. Seattle Genetics. Pfizer. MacroGenics. Celldex Therapeutics. CureTech.
20 Oct 2020
These Weak Stocks To Consider Selling? Checkpoint Therapeutics Inc. (CKPT) and Textainer Group Holdings Limited (TGH)
Checkpoint Therapeutics Inc. (CKPT) and Textainer Group Holdings Limited (TGH). By. Melanie Gerald. -. October 20, 2020.
20 Oct 2020
Immune Checkpoint Inhibitors Market | Global Industry ...
Merck & Co. Roche / Genentech Incyte Corporation NewLink Genetics ArGEN-X Seattle Genetics Pfizer MacroGenics. Celldex Therapeutics CureTech. Immutep
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Checkpoint Therapeutics, Inc. | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
Checkpoint Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Checkpoint Therapeutics, Inc. | $1,319 | $23,425 | $-21,958 | $165.415M | 225 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |